Effects of Hormonal Replacement Therapy and Mindfulness-Based Stress Reduction on Climacteric Symptoms Following Risk-Reducing Salpingo-Oophorectomy.

Autor:	Ali, Amira Mohammed, Al-Dossary, Saeed A., Laranjeira, Carlos, Amer, Faten, Hallit, Souheil, Alkhamees, Abdulmajeed A., Aljubilah, Aljawharah Fahad, Aljaberi, Musheer A., Alzeiby, Ebtesam Abdullah, Fadlalmola, Hammad Ali, Pakai, Annamaria, Khatatbeh, Haitham
Předmět:	PERIMENOPAUSE CROSS-sectional method SALPINGO-oophorectomy PSYCHOLOGICAL distress STRESS management BRCA genes SECONDARY analysis BODY mass index RESEARCH funding OVARIAN tumors GENITOURINARY diseases MINDFULNESS QUESTIONNAIRES TREATMENT effectiveness DESCRIPTIVE statistics CHI-squared test PATH analysis (Statistics) HORMONE therapy QUALITY of life SOCIODEMOGRAPHIC factors COMPARATIVE studies DATA analysis software CLIMACTERIC
Zdroj:	Healthcare (2227-9032); Aug2024, Vol. 12 Issue 16, p1612, 17p
Abstrakt:	Breast Cancer Associated Susceptibility Proteins Type 1/2 (BRCA1/2) promote cellular functioning by modulating NRF2-mediated antioxidant signaling. Redox failure in women with BRCA1/2 insufficiency increases the risk for breast/ovarian/uterine cancers. Risk-reducing salpingo-oophorectomy (RRSO) is a prophylactic surgery of the reproductive organs, which is frequently conducted by the age of 40 to lower the occurrence of cancer in women with BRCA1/2 mutations. However, abrupt estrogen decline following RRSO causes ovarian failure, which implicates various cellular physiological processes, resulting in the increased release of free radicals and subsequent severe onset of menopausal symptoms. Comfort measures (e.g., hormonal replacement therapy (HRT) and mindfulness-based stress reduction (MBSR)) may improve chronological menopause-related quality of life, but their specific effects are not clear in women with gene mutations. Aiming to fill the gap, this study used path analysis to examine the effects of HRT and MBSR on menopausal symptoms among RRSO patients (N = 199, mean age = 50.5 ± 6.7 years). HRT directly alleviated the levels of urogenital symptoms (β = −0.195, p = 0.005), which mediated its indirect significant effects on the somatic–vegetative and psychological symptoms of menopause (β = −0.046, −0.067; both p values = 0.004, respectively), especially in BRCA2 carriers and in women who were currently physically active, premenopausal at the time of RRSO, had a high BMI, and had no history of breast cancer. It increased the severity of urogenital symptoms in women with a history of cancer. MBSR, on the other hand, was associated with indirect increases in the intensity of the somatic–vegetative and psychological symptoms of menopause (β = 0.108, 0.029; p = 0.003, 0.033, respectively). It exerted positive direct effects on different menopausal symptoms in multigroup analysis. The results suggest that young women undergoing recent RRSO may benefit from HRT at an individual level, while their need for extensive measures to optimize their psychological wellbeing is ongoing. The adverse effects of MBSR, which are captured in the present study, imply that MBSR may interfere with redox sensitivity associated with estradiol fluctuations in BRCA1/2 carriers. Investigations are needed to test this hypothesis and elaborate on the underlying mechanisms in these women. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu